ReFRM3D: A Radiomics-enhanced Fused Residual Multiparametric 3D Network with Multi-Scale Feature Fusion for Glioma Characterization
By: Md. Abdur Rahman , Mohaimenul Azam Khan Raiaan , Arefin Ittesafun Abian and more
Potential Business Impact:
Helps doctors find brain tumors faster and better.
Gliomas are among the most aggressive cancers, characterized by high mortality rates and complex diagnostic processes. Existing studies on glioma diagnosis and classification often describe issues such as high variability in imaging data, inadequate optimization of computational resources, and inefficient segmentation and classification of gliomas. To address these challenges, we propose novel techniques utilizing multi-parametric MRI data to enhance tumor segmentation and classification efficiency. Our work introduces the first-ever radiomics-enhanced fused residual multiparametric 3D network (ReFRM3D) for brain tumor characterization, which is based on a 3D U-Net architecture and features multi-scale feature fusion, hybrid upsampling, and an extended residual skip mechanism. Additionally, we propose a multi-feature tumor marker-based classifier that leverages radiomic features extracted from the segmented regions. Experimental results demonstrate significant improvements in segmentation performance across the BraTS2019, BraTS2020, and BraTS2021 datasets, achieving high Dice Similarity Coefficients (DSC) of 94.04%, 92.68%, and 93.64% for whole tumor (WT), enhancing tumor (ET), and tumor core (TC) respectively in BraTS2019; 94.09%, 92.91%, and 93.84% in BraTS2020; and 93.70%, 90.36%, and 92.13% in BraTS2021.
Similar Papers
Revolutionizing Glioma Segmentation & Grading Using 3D MRI - Guided Hybrid Deep Learning Models
CV and Pattern Recognition
Finds brain tumors faster and more accurately.
ReCoSeg++:Extended Residual-Guided Cross-Modal Diffusion for Brain Tumor Segmentation
Image and Video Processing
Finds brain tumors better in MRI scans.
Predicting Brain Tumor Response to Therapy using a Hybrid Deep Learning and Radiomics Approach
CV and Pattern Recognition
Helps doctors see if cancer treatment works.